Shares for Interest Debt Settlement; Grants Options

December 15, 2022 09:49 ET | Source: Arch Biopartners TORONTO, Dec. 15, 2022 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the Company has arranged a shares for debt transaction to settle an aggregate of $201,459 in interest accrued up to September 30, 2022 … Read more